Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Mundipharma Extends Nutraceutical Portfolio with launch of Maxvida(TM) in Vietnam

SINGAPORE, May 13, 2019 /PRNewswire/ -- Mundipharma has extended its portfolio of nutraceuticals by launchingMaxvida(TM) - a balanced nutritional supplement with 32 key nutrients - inVietnam. Mundipharma will subsequently look at other countries in the region to distribute the product, which was...

2019-05-13 16:44 3641

The Seventh HIMSS-Elsevier Digital Healthcare Award in APAC Opens for Submissions

SINGAPORE, May 13, 2019 /PRNewswire/ -- HIMSS Asia Pacific and Elsevier are proud to announce the call for submissions for the 7th Annual Asia Pacific (APAC) HIMSS-Elsevier Digital Healthcare Award 2019. "The 7th annual HIMSS-Elsevier APAC award is a really significant initiative that was f...

2019-05-13 09:00 1953

China Biologic Reports Financial Results for the First Quarter of 2019

--1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms -- BEIJING, May 10, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"...

2019-05-11 04:30 9549

NeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDA

LUND, Sweden, May 10, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the US Food and Drug Administration, FDA, has approved NeuroVive's IND (Investigational New Drug) application, enabling clinical studies in the US with the company's ...

2019-05-10 15:05 5675

Ally Bridge Group Leads Pulmonx's $65 Million Financing, Further Strengthening Its Global Medtech Franchise

HONG KONG, May 10, 2019 /PRNewswire/ -- Ally Bridge Group ("ABG"), a leading global life science investment group, announced today that it led an over-subscribed$65 million financing of Pulmonx Corporation, a global leader in diagnostic and therapeutic pulmonary device technologies with its key p...

2019-05-10 10:05 3115

OliX Pharmaceuticals Expands Ocular Disease Pipeline; Adds OLX304A for the Treatment of Retinitis Pigmentosa

SUWON, South Korea, May 9, 2019 /PRNewswire/ -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics,announced today an expansion of its ocular disease pipeline. Specifically, the company announced that OLX304A has been added to develop an RNAi therapeutic with...

2019-05-10 09:24 1558

MLP Care's Strong Start to the First Quarter of 2019

ISTANBUL, May 10, 2019 /PRNewswire/ -- * In the first quarter of 2019, MLP Care's revenue (BIST: MPARK) increased to TL933 million, up by 25%. When revenues of managed hospitals are included, revenue growth in Q1 2019 is at 28% * Adj. EBITDA increased by 20%, bringing EBITDA margin to 18.0%....

2019-05-10 09:00 3104

EnGeneIC Announces First Patients with Advanced-Stage Pancreatic Cancer Dosed in Phase 1/2a Clinical Study of Targeted Cytotoxic Immunotherapy

NEW YORK and SYDNEY, May 10, 2019 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platform for targeted cyto-immunotherapy in cancer, today announced that the first four patients have been dosed in a Phase 1/2a study using the ...

2019-05-10 05:05 1146

Varex To Highlight Advanced Imaging Components At China International Medical Equipment Fair In Shanghai

Varex To Launch 'Local for Local' Campaign At CMEF Varex at CMEF 2019: Booth #1D11 May 14-17, 2019 Conference & Exhibit: China International Medical Equipment Fair National Convention & Exhibition Center, Shanghai, China SALT LAKE CITY, May 9, 2019 /PRNewswire/ -- Varex Imaging Corporation (Na...

2019-05-09 20:30 2842

CloudMinds Partners with Retail Pharmacy Giant in U.S., Introducing Powerful Cloud AI Solution for Healthcare

BEIJING, May 9, 2019 /PRNewswire/ -- Artificial intelligence (AI) is pioneering a new wave of innovation in the medical industry prompting large healthcare providers to quickly implement AI to adapt to this technological revolution. AI has become a key strategic focal point for retail pharmacies,...

2019-05-09 16:47 2273

CloudMinds Partners with Retail Pharmacy Giant in U.S., Introducing Powerful Cloud AI Solution for Healthcare

People with lupus feel the disease greatly affects their emotional and mental well-being

World Lupus Federation global survey highlights the need for education, specialty care and emotional support for millions of people living with lupus WASHINGTON, May 9, 2019 /PRNewswire/ -- More than 6 in 10 (61.6%) people living with lupus say the disease has had 'a lot' of effect on their emoti...

2019-05-09 12:01 935

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

REHOVOT, Israel, May 9, 2019 /PRNewswire/ -- Pi-Cardia Ltd. (www.pi-cardia.net ), announced today that it successfully completed the First-in-Human (FIH) studies with its Leaflex™ Performer catheter. The Leaflex™ Performer is a trans-femoral catheter that uses two unique...

2019-05-09 09:00 1928

AIMed and Best Case Scenario Announce New Partnership to Launch AIMed Australia

ORANGE, California, May 9, 2019 /PRNewswire/ -- AIMed, a leading provider of global clinician-led artificial intelligence events, education and editorial content in healthcare and medicine has announced today a new partnership with Best Case Scenario (BCS), a leading event management company base...

2019-05-09 07:00 1229

AirXpanders Engages Cowen to Explore Financial and Strategic Alternatives

SAN JOSE, California, May 9, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the Company has retained Cowen as an independent financial advisor to as...

2019-05-09 03:29 914

United Imaging Healthcare uPMR 790 HD TOF PET/MR Cleared by FDA

HOUSTON, May 8, 2019 /PRNewswire/ -- United Imaging Healthcare (UIH), an international leader in advanced medical imaging and radiotherapy equipment, announced the U.S. Food and Drug Administration (FDA) clearance of the uPMR 790 HD TOF PET/MR. uPMR 790 redefines clinical routine imaging for PET/...

2019-05-08 20:00 1130

Kazia calls for greater awareness of the deadliest gynecological cancer in the US

SYDNEY, May 8, 2019 /PRNewswire/ -- This World Ovarian Cancer Day, Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) calls for greater awareness of what is the most lethal gynaecological cancer in the US. In 2019, around 22,530 women will receive a new d...

2019-05-08 20:00 6262

Vietnam's "K Hospital" Uses Elekta Solutions to Make Precision Radiation Medicine Available to Cancer Patients

HANOI, Vietnam, May 8, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today thatVietnam's National Cancer Hospital, which is affiliated with the K Hospital, will soon begin treating cancer patients with advanced technology from Elekta. The K hospital has invested in a Leksell Gamma Knife® Icon...

2019-05-08 14:36 1322

Kazia calls for greater awareness of the most lethal women's disease in Australia

SYDNEY, May 8, 2019 /PRNewswire/ -- This World Ovarian Cancer Day, Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) calls for greater awareness of what is the most lethal women's disease in Australia. Every year, approximately 1,600 Australian women are...

2019-05-08 09:55 6350

GeneQuantum Healthcare completed nearly RMB 100 million in Pre-B financing

SUZHOU, China, May 7, 2019 /PRNewswire/ -- GeneQuantum Healthcare announced that it has closed nearlyRMB 100 million Pre-B round of financing. This financing was led by Huagai Capital, joined by Hofon Capital and Changjinboya. GeneQuantum Healthcare's A-round investor Oriza Seed and TF Capital co...

2019-05-08 08:00 1447

Two Clinical Studies with IBI301, a Biosimilar Candidate to Rituximab, Met Primary Endpoints

SUZHOU, China, May 8, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801) and Eli Lilly and Company ("Lilly") jointly announced today that IBI301, a recombinant human-mouse chimeric anti-cell surface protein (anti-CD20) monoclonal antibody being co-developed as a potential bios...

2019-05-08 08:00 8067

1 ... 573 574 575576577